JP7511596B2 - リバーロキサバン含有錠剤 - Google Patents

リバーロキサバン含有錠剤 Download PDF

Info

Publication number
JP7511596B2
JP7511596B2 JP2022052554A JP2022052554A JP7511596B2 JP 7511596 B2 JP7511596 B2 JP 7511596B2 JP 2022052554 A JP2022052554 A JP 2022052554A JP 2022052554 A JP2022052554 A JP 2022052554A JP 7511596 B2 JP7511596 B2 JP 7511596B2
Authority
JP
Japan
Prior art keywords
tablet
rivaroxaban
cellulose
hydroxypropyl cellulose
tablet according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022052554A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022140430A (ja
JP2022140430A5 (enrdf_load_stackoverflow
Inventor
究 大崎
俊 加藤
Original Assignee
日本ジェネリック株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日本ジェネリック株式会社 filed Critical 日本ジェネリック株式会社
Publication of JP2022140430A publication Critical patent/JP2022140430A/ja
Publication of JP2022140430A5 publication Critical patent/JP2022140430A5/ja
Application granted granted Critical
Publication of JP7511596B2 publication Critical patent/JP7511596B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2022052554A 2021-03-10 2022-03-09 リバーロキサバン含有錠剤 Active JP7511596B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021074453 2021-03-10
JP2021074453 2021-03-10

Publications (3)

Publication Number Publication Date
JP2022140430A JP2022140430A (ja) 2022-09-26
JP2022140430A5 JP2022140430A5 (enrdf_load_stackoverflow) 2023-11-10
JP7511596B2 true JP7511596B2 (ja) 2024-07-05

Family

ID=83399839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022052554A Active JP7511596B2 (ja) 2021-03-10 2022-03-09 リバーロキサバン含有錠剤

Country Status (1)

Country Link
JP (1) JP7511596B2 (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118001245B (zh) * 2024-03-13 2024-08-27 广东粤和泽药物研究有限公司 一种利伐沙班口腔崩解片及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007512274A (ja) 2003-11-27 2007-05-17 バイエル・ヘルスケア・アクチェンゲゼルシャフト 固体の経口投与可能な医薬組成物の製造方法
CN105457036A (zh) 2014-08-08 2016-04-06 天津汉瑞药业有限公司 一种利伐沙班药物组合物及其制备方法
JP2021195335A (ja) 2020-06-15 2021-12-27 沢井製薬株式会社 リバーロキサバン含有口腔内崩壊錠の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1100469T1 (enrdf_load_stackoverflow) * 1998-07-28 2005-08-31 Takeda Pharmaceutical
DE102005047561A1 (de) * 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
US20190046449A1 (en) * 2016-02-25 2019-02-14 Mylan Inc. A unique high-shear granulation process for improved bioavailability of rivaroxaban
JP6574041B2 (ja) * 2017-12-15 2019-09-11 エルメッド株式会社 リバーロキサバン含有医薬組成物
JP6824549B2 (ja) * 2018-09-25 2021-02-03 日新製薬株式会社 経口固形製剤およびその製造法
CN111355313A (zh) * 2018-12-24 2020-06-30 日本电产株式会社 一种轴向磁通马达以及电气产品
CN109620961A (zh) * 2019-01-20 2019-04-16 黄泳华 由吗啉酮衍生物与纤维素衍生物构成的组合物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007512274A (ja) 2003-11-27 2007-05-17 バイエル・ヘルスケア・アクチェンゲゼルシャフト 固体の経口投与可能な医薬組成物の製造方法
CN105457036A (zh) 2014-08-08 2016-04-06 天津汉瑞药业有限公司 一种利伐沙班药物组合物及其制备方法
JP2021195335A (ja) 2020-06-15 2021-12-27 沢井製薬株式会社 リバーロキサバン含有口腔内崩壊錠の製造方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
医薬品添加物事典２０１６，第３４０頁，２０１６年２月１８日発行，株式会社 薬事日報社
添加剤の特性・選び方・使い方ノウハウ集，第３０～３８頁，２０１２年１月３１日発行、株式会社 技術情報協会

Also Published As

Publication number Publication date
JP2022140430A (ja) 2022-09-26

Similar Documents

Publication Publication Date Title
JP6545839B2 (ja) 口腔内崩壊錠及びその製造方法
JP4852423B2 (ja) 固体の経口投与可能な医薬組成物の製造方法
CN106943355B (zh) 药物组合物
JP2022016638A (ja) イルベサルタンとアムロジピンまたはその塩を含有する医薬組成物
JP5289338B2 (ja) 医薬固形製剤及びその製造方法
TW201827049A (zh) 含二胺衍生物之口腔崩散錠
CN107249590A (zh) 固体制剂
JPWO2013022059A1 (ja) ジアミン誘導体含有医薬組成物
JP7571394B2 (ja) エドキサバンを含有する口腔内崩壊錠
JP2013532651A (ja) シロドシンと塩基性コポリマーとの混合物を含む経口投与用医薬品
JP2010519200A (ja) シロスタゾールを含む制御放出製剤及びその製造方法
JP7641098B2 (ja) リバーロキサバン含有錠剤
JP7465157B2 (ja) リバーロキサバン含有口腔内崩壊錠の製造方法
JP2012149056A (ja) 新規な安定化固形製剤
JP7511596B2 (ja) リバーロキサバン含有錠剤
JP7629290B2 (ja) エドキサバン含有造粒物及び口腔内崩壊錠
JP2014037356A (ja) カンデサルタンシレキセチル経口製剤
JP6813822B2 (ja) アトモキセチン錠剤およびアトモキセチン錠剤の製造方法
RU2674978C2 (ru) Фармацевтическая композиция N-[5-[2-(3,5-диметоксифенил)этил]-2H-пиразол-3-ил]-4-[(3R,5S)-3,5-диметилпиперазин-1-ил]бензамида
JP2021063055A (ja) エドキサバン含有錠剤
JP6321131B2 (ja) アムロジピン含有配合錠の溶出性改善方法
JP2015503555A (ja) ボセンタン制御放出性経口製剤
JP2022074102A (ja) リバーロキサバン含有固形製剤
TW201803555A (zh) 口腔內崩解錠添加用組成物
KR20160141045A (ko) 보센탄을 함유한 약학적 조성물

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231006

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231006

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20231006

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20231005

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231120

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240119

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240311

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240516

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240625

R150 Certificate of patent or registration of utility model

Ref document number: 7511596

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350